Repositori institucional URV
Español Català English
TITLE:
Circulating FABP4 is a marker of metabolic and cardiovascular risk in SLE patients - imarina:563747

URV's Author/s:CABRÉ LLOBET, ANNA / Castro Salomó, Antoni / FERRÉ VALLÈS, RAIMON / HERAS IBAÑEZ, MERCEDES / Marimon Cortes, Francesc / Masana Marín, Luis / Parra Pérez, Sandra / Ribalta Vives, Josep
Author, as appears in the article.:Parra, S; Cabré, A; Marimon, F; Ferré, R; Ribalta, J; Gonzàlez, M; Heras, M; Castro, A; Masana, L
Author's mail:francesc.marimon@urv.cat
sandra.parra@urv.cat
antoni.castro@urv.cat
luis.masana@urv.cat
josep.ribalta@urv.cat
Author identifier:0000-0001-9363-6574
0000-0001-5441-6333
0000-0002-0789-4954
0000-0002-8879-4719
Journal publication year:2014
Publication Type:Journal Publications
ISSN:09612033
APA:Parra, S; Cabré, A; Marimon, F; Ferré, R; Ribalta, J; Gonzàlez, M; Heras, M; Castro, A; Masana, L (2014). Circulating FABP4 is a marker of metabolic and cardiovascular risk in SLE patients. Lupus, 23(3), 245-254. DOI: 10.1177/0961203313517405
Papper original source:Lupus. 23 (3): 245-254
Abstract:The aim of this study is to determine if circulating fatty acid-binding protein 4 (FABP4) plasma levels are a possible marker of metabolic risk in SLE patients. Circulating levels of adipose FABP4 are associated with adiposity, insulin resistance (IR), metabolic syndrome, diabetes and cardiovascular diseases. Patients affected by systemic lupus erythematosus (SLE) show an accelerated atherosclerosis that cannot be entirely explained by traditional cardiovascular risk factors. Sixty consecutive patients with SLE and 34 non-SLE age-matched controls were recruited for the study. Total plasma lipids and circulating FABP4 were determined. Subclinical atherosclerosis was evaluated by measuring carotid intimae-media thickness (c-IMT) by sonography, and the distribution of lipoprotein subclasses was analysed by nuclear magnetic resonance (NMR) spectroscopy. In the SLE group, FABP4 was associated with IR, atherogenic dyslipidaemia, as measured by NMR, and the presence of subclinical atherosclerosis. In multivariate analyses FABP4 was associated with increased c-IMT independent of the inflammatory state of the patient. In sum, circulating FABP4 is involved in the metabolic disturbances of SLE affecting lipid metabolism and IR, and it could be a biomarker of atherosclerosis in this population.
Article's DOI:10.1177/0961203313517405
Link to the original source:https://journals.sagepub.com/doi/10.1177/0961203313517405
Papper version:info:eu-repo/semantics/submittedVersion
licence for use:https://creativecommons.org/licenses/by/3.0/es/
Department:Medicina i Cirurgia
Licence document URL:https://repositori.urv.cat/ca/proteccio-de-dades/
Thematic Areas:Zootecnia / recursos pesqueiros
Saúde coletiva
Rheumatology
Odontología
Nutrição
Medicina veterinaria
Medicina iii
Medicina ii
Medicina i
Interdisciplinar
General medicine
Farmacia
Educação física
Ciências biológicas iii
Ciências biológicas ii
Ciências biológicas i
Biotecnología
Antropologia / arqueologia
Keywords:Systemic lupus erythematosus
Spain
Risk factors
Prognosis
Prevalence
Multivariate analysis
Middle aged
Metabolic syndrome
Magnetic resonance spectroscopy
Lupus erythematosus, systemic
Lipids
Linear models
Humans
Haematologic
Female
Fatty acid-binding proteins
Fabp4 protein, human
Cross-sectional studies
Changes
Case-control studies
Carotid intima-media thickness
Carotid artery diseases
Cardiovascular disease
Biomarkers
Asymptomatic diseases
Aged
Adult
systemic lupus erythematosus
changes
cardiovascular disease
Entity:Universitat Rovira i Virgili
Record's date:2025-01-08
Search your record at:

Available files
FileDescriptionFormat
DocumentPrincipalDocumentPrincipalapplication/pdf

Information

© 2011 Universitat Rovira i Virgili